Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells
2010
How Osteopontin Affects Cancer Cell Signaling
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Brian W. Robertson, Lauren Bonsal, Meenakshi A. Chellaiah
Primary Institution: University of Maryland, Baltimore
Hypothesis
Does osteopontin activate the Erk1/2 signaling pathway in prostate cancer cells through specific receptors?
Conclusion
Osteopontin activates the Erk1/2 pathway in prostate cancer cells, but also inhibits it through the Akt pathway.
Supporting Evidence
- Osteopontin can activate Akt through integrin αvβ3 and CD44 receptors.
- Inhibition of Akt increases the phosphorylation of Erk1/2.
- The study shows that OPN has dual effects on the Erk1/2 pathway.
Takeaway
Osteopontin helps cancer cells grow by turning on certain signals, but it can also slow them down by using another signal.
Methodology
The study used PC3 prostate cancer cell lines to investigate the effects of osteopontin on signaling pathways.
Limitations
The study primarily focuses on a single cell line, which may not represent all prostate cancer types.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website